Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extracellular Vesicles for Knee Osteoarthritis
NCT06937528Phase 1Recruiting
- Sponsor
- University of Jordan
- Start
- Jan 2024
- Primary completion
- Jan 2026
- Modality
- Lipid-based Nanoparticles, Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Extracellular vesicles (University of Jordan) in knee osteoarthritis (OA), sponsored by University of Jordan. Primary endpoint: Safety at 12 months. Started Jan 2024; status: recruiting.
02
Drugs
Extracellular vesicles (University of Jordan)
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06937528.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06937528.